BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38139811)

  • 1. A Critical Interpretive Synthesis of the Role of Arecoline in Oral Carcinogenesis: Is the Local Cholinergic Axis a Missing Link in Disease Pathophysiology?
    Gocol H; Zeng JH; Chang S; Koh BY; Nguyen H; Cirillo N
    Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
    Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
    BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
    Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
    J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and FAT1 expressions.
    Kuo TM; Nithiyanantham S; Lee CP; Hsu HT; Luo SY; Lin YZ; Yeh KT; Ko YC
    J Cell Physiol; 2019 Aug; 234(8):13984-13993. PubMed ID: 30624777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
    Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
    J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
    Yu CC; Tsai CH; Hsu HI; Chang YC
    PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
    Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
    Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
    Khan I; Kumar N; Pant I; Narra S; Kondaiah P
    PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat mass and obesity-associated protein regulates arecoline-exposed oral cancer immune response through programmed cell death-ligand 1.
    Li X; Chen W; Gao Y; Song J; Gu Y; Zhang J; Cheng X; Ai Y
    Cancer Sci; 2022 Sep; 113(9):2962-2973. PubMed ID: 35289035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
    Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
    J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral submucous fibrosis: review on aetiology and pathogenesis.
    Tilakaratne WM; Klinikowski MF; Saku T; Peters TJ; Warnakulasuriya S
    Oral Oncol; 2006 Jul; 42(6):561-8. PubMed ID: 16311067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
    Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
    J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of O(6) -methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline.
    Lee SS; Tsai CH; Yu CC; Ho YC; Hsu HI; Chang YC
    J Oral Pathol Med; 2013 Sep; 42(8):600-5. PubMed ID: 23278137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review of Roles of Arecoline and Arecoline
    Ko AM; Tu HP; Ko YC
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
    Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
    Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine sulphation of CXCR4 induces the migration of fibroblast in OSF.
    He C; Wang W; Wan W; Liang J; Hu J; Yuan Y; Jiang C; Li N
    Oral Dis; 2023 May; 29(4):1782-1790. PubMed ID: 35150031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arecoline N-oxide: its mutagenicity and possible role as ultimate carcinogen in areca oral carcinogenesis.
    Lin KH; Lin CY; Liu CC; Chou MY; Lin JK
    J Agric Food Chem; 2011 Apr; 59(7):3420-8. PubMed ID: 21370913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
    Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
    Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
    Hsieh YP; Chen HM; Chang JZ; Chiang CP; Deng YT; Kuo MY
    Head Neck; 2015 Apr; 37(4):493-7. PubMed ID: 24436257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
    Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
    J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.